A detailed history of Headlands Technologies LLC transactions in Mannkind Corp stock. As of the latest transaction made, Headlands Technologies LLC holds 577 shares of MNKD stock, worth $3,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
577
Holding current value
$3,952
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.01 - $6.7 $2,890 - $3,865
577 New
577 $3,000
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $2,135 - $3,796
707 New
707 $4,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.